US federal debt tops $39T and rising—learn what higher interest rates could mean for stocks, housing, and why short-term ...

Molbio Diagnostics shares listed at ₹980, a 21.44% premium to its ₹807 IPO price. Explore its valuation, Truenat growth, key price levels, risks and investor outlook.

This eBook explores the latest advances in reproductive health research, covering fertility decline, endometriosis diagnostics, fetal therapies, environmental risks, male contraceptives, and ovarian ...

Canadian Natural's (TSX: CNQ) (NYSE: CNQ) President, Scott Stauth, commented on the Company's 2024 fourth quarter and year end results, "2024 was an ...

On December 19, 2025, the Company had allotted 1,526,495,460 bonus equity shares of I 1/- each (fully paid up) in the proportion of 3 bonus equity shares for every 1 fully paid up equity share to ...

Our accounts and fund had a generally flat first half performance, with accounts down 3.6% vs. +11.7% for the MSCI ACWI index. We believe that the e-commerce business will become more and more ...

Second Quarter 2026 Financial Highlights (Compared to the Second Quarter of 2025): Revenue of $8.1 million, an increase of 13.3% compared to $7.1 million, an over 8-year record. Gross Profit of $4.9 ...

This valuable study provides key insights into the role of the G protein-coupled receptor GPR34 in an Alzheimer's disease (AD) model. Notably, its findings differ, at least in part, from those of ...

Asia’s emerging economies and the Middle East & Africa offer strong opportunities amid urbanization and industrialization. The report analyzes market trends, applications, regions and leading ...